Community/Retail

West Virginia's highest appellate court recently ruled prescription drug abusers can sue pharmacists for enabling their addictions.

Census data suggest independent pharmacies continue to do well.

Later this week, Cardinal Health Specialty Solutions will present a new series of health economic outcomes research (HEOR) studies.

Amgen has terminated its co-development and commercialization of brodalumab with AstraZeneca after observing suicidal ideation and behavior in clinical trial participants.

Light or moderate alcohol intake has been associated with health benefits such as reduced risk of cardiovascular events, but these benefits disappear as intake increases.

Initiative supported by Actavis aims to help advance evidence-based treatment practices using unique data-sharing platform.

The FDA today approved a new 200 unit/mL formulation of Lilly's Humalog KwikPen for patients with type 1 and type 2 diabetes.

Noting national drug shortages often disproportionately affect pediatric patients, the Pediatric Pharmacy Advocacy Group (PPAG) is encouraging the FDA to include child-specific considerations in its policies for preventing and mitigating drug shortages.

Kevin Pak, pharmacy student at Philadelphia College of Pharmacy at the University of the Sciences, talks about a challenge that pharmacists are facing.

These are the top traits I look for in a pharmacy technician.

Hospitals serving large populations of non-native English speakers perform worse on patient satisfaction scores that are tied to reimbursement from the US Centers for Medicare and Medicaid Services.

The FDA today approved a new treatment for chronic obstructive pulmonary disease: tiotropium bromide and olodaterol inhalation spray.

AbbVie (NYSE: ABBV), a global biopharmaceutical company, announced today that it has completed the acquisition of Pharmacyclics, Inc.

Sanofi today announced the appointment of Suresh Kumar as a new member of the Executive Committee, effective June 1, 2015.

The future of pharmacy is uncertain at best.

The FDA had accepted for review Tris Pharma's New Drug Application for its extended-release liquid amphetamine to treat ADHD in children.

While pharmacy technicians have taken on increasingly important responsibilities, their roles on the pharmacy team often go unrecognized by the patients they serve.

Electronic prescribing technology is permitting pharmacists to focus less on administrative tasks and more on providing direct patient care.

The American Society of Health-System Pharmacists recently released its Pharmacy Forecast projecting changes in the pharmacy profession over the next 5 years.

Shaun Ellen Gleason, PharmD, MGS, assistant professor at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, talks about what drew her to teaching pharmacy students.

Mylan N.V. today announced that it was asked by the Irish Takeover Panel to issue the following clarification and retraction in accordance with the Irish Takeover Rules (the "Rules").

The National Association of Boards of Pharmacy® (NABP®) is pleased to announce that general availability for the .pharmacy domain begins June 3, 2015.

Although previous reports focused on the risks of antidepressant use in new mothers, a recent study stressed the benefits these drugs provide for women with postpartum depression.

Commonly, patients have read on the Internet that a generic medication may be anywhere from 25% more potent to 20% less potent than its brand-name equivalent.

Clostridium difficile-associated diarrhea (CDAD) is an increasingly common cause of inpatient mortality, and recurrent CDAD remains clinically challenging.

Patients inaccurately diagnosed by their health care providers are more likely to receive inappropriate antibiotics that can lead to drug resistance, clinical failure, and adverse events.

To give health-system pharmacists more time to concentrate on patient-centered care, a hospital has enlisted the help of a robot named Tug to deliver medications to nursing stations.

Women with the greatest risk for osteoporosis are not being screened enough, while those at less risk are being screened too often.

The FDA is warning health care professionals about the risk for dosing errors with ceftolozane and tazobactam (Zerbaxa).

Patients with heart failure often receive clopidogrel and angiotensin-converting enzyme inhibitors concurrently.